Home

Team

Investment Approach

For Entrepreneurs

Portfolio Companies

News & Events

Archive

News & Events

Page 1

Peplin secures approximately US$24m in additional financing

18 / 08 / 2008

Peplin Announces Executive Management Appointments

18 / 08 / 2008

Additional information lodged with FDA for US clinical trial

13 / 08 / 2008

Sales contracts worth $2.3 million signed since 1 July 2008

12 / 08 / 2008

Australian company Xenome presents Xen2174 data on relief of pain in cancer patients at international conference

01 / 08 / 2008

KaloBios Initiates Phase 1/2 Trial of HumaneeredT Monoclonal Antibody KB001 for Treatment of Pseudomonas Infections in Mechanically Ventilated Patients

19 / 05 / 2008

Uptake Medical Announces Successful Completion of Patient Enrollment in Pilot Safety & Feasibility Clinical Trial for Patients with Heterogeneous Emphysema

16 / 05 / 2008

Novasys Medical Secures $49.5 Million in Series D Financing to Expand Commercialization of its Renessar Treatment for Incontinence in Women

15 / 05 / 2008

Underwritten rights issue to raise $5.4 million

05 / 05 / 2008

KaloBios Expands Senior Management Team -- Adds Project Management and Additional Business Development Expertise --

05 / 05 / 2008

KaloBios Completes Patient Dosing in its U.S. Phase 1 Trial of Its Third Drug Candidate, KB003 -- First HumaneeredT Anti-GM-CSF Monoclonal Antibody Part of Comprehensive Inflammation Development Program --

28 / 04 / 2008

Portland Orthopaedics Share Purchase Plan closes

15 / 04 / 2008

ChemGenex Reports Oral Bioavailability of Omacetaxine and Expands on Mechanism of Action

15 / 04 / 2008

C-Pulse abstract presented at ISHLT Meeting, Boston

08 / 04 / 2008

New Therapies Fight Phantom Noises of Tinnitus

01 / 04 / 2008

ChemGenex Investigators Present Data on Clinical Activity of Omacetaxine in Imatinib-Resistant Chronic Myeloid Leukemia Patients with the T315I Mutation at International Leukemia Conference

01 / 04 / 2008

KaloBios Initiates Phase 1/2 Trial of HumaneeredT Monoclonal Antibody KB001 for Treatment of Pseudomonas Infections in Cystic Fibrosis Patients

31 / 03 / 2008

ChemGenex Launches Multi-Site Omacetaxine Clinical Trial in AML Patients

11 / 03 / 2008

KaloBios Initiates Phase 1/2 Trial of KB002 Engineered Monoclonal Antibody in Persistent Asthma

10 / 03 / 2008

PHARMAXIS' FIRST STEPS INTO CHINA

07 / 03 / 2008

Portland adopts innovative financing with NAB

27 / 02 / 2008

Portland Orthopaedics appoints Australian distributor

26 / 02 / 2008

Displaying records 26-47 of 47